Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of LXRX by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−35,738−100.0%Sold outHolders
Q3 202535,738$48.0K<0.1%−55,126−60.7%ReducedHolders
Q2 202590,864$86.0K<0.1%00.0%UnchangedHolders
Q1 202590,864$42.0K<0.1%−10,284−10.2%ReducedHolders
Q4 2024101,148$75.0K<0.1%−7,586−7.0%ReducedHolders
Q3 2024108,734$171.0K<0.1%+7,600+7.5%AddedHolders
Q2 2024101,134$170.0K<0.1%+5,950+6.3%AddedHolders
Q1 202495,184$228.0K<0.1%+61,000+178.4%AddedHolders
Q4 202334,184$52.0K<0.1%−5,385−13.6%ReducedHolders
Q3 202339,569$43.0K<0.1%+24,400+160.9%AddedHolders
Q2 202315,169$35.0K<0.1%+1,100+7.8%AddedHolders
Q1 202314,069$34.0K<0.1%−10,400−42.5%ReducedHolders
Q4 202224,469$46.0K<0.1%−107−0.4%ReducedHolders
Q3 202224,576$58.0K<0.1%00.0%UnchangedHolders
Q2 202224,576$45.0K<0.1%+10,300+72.1%AddedHolders
Q1 202214,276$29.0K<0.1%00.0%UnchangedHolders
Q4 202114,276$56.0K<0.1%00.0%UnchangedHolders
Q3 202114,276$68.0K<0.1%+107+0.8%AddedHolders
Q2 202114,169$65.0K<0.1%00.0%UnchangedHolders
Q1 202114,169$83.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.